logo-loader
viewAIM ImmunoTech Inc.

Medsea Estates Group - Update re Report & Accounts

RNS Number:4368T Medsea Estates Group PLC 30 April 2008 MEDSEA ESTATES GROUP PLC Update re Report & Accounts Medsea Estates Group PLC announces that there has been a delay in finalising its 2007 Report and Accounts and that a release date will be notified in due course. For further information: Medsea Estates Group plc Tony Gatehouse, Chairman Tel: +34 96 570 40 02 Juan Carlos Rodriguez Martinez, Chief Executive HB Corporate Edward Hutton /Imran Ahmad Tel: +44 (0) 207 510 8600 Media enquiries: Threadneedle Communications Alex White/Josh Royston Tel: +44 (0) 207 936 9665 This information is provided by RNS The company news service from the London Stock Exchange END MSCKGGFDGGKGRZM

Quick facts: AIM ImmunoTech Inc.

Price: 0.4851

Market: NYSE
Market Cap: $2.35 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Hemispherx Biopharma releases 'well tolerated' data for...

Hemispherx Biopharma Inc (NYSEAMERICAN:HEB) CEO Thomas Equels tells Protactive that a final report on its phase 1 trial supporting the safety of using its flagship drug Ampligen as a combination therapy to treat recurrent ovarian cancer found that it was “well tolerated." Equels explains the...

on 08/19/2019

RNS